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1. Introduction
Mycotoxins contaminate many staple food crops and crops 
used in animal feed, particularly in sub-Saharan Africa and 
Asia. Several mycotoxins have been identified, however, 
those that are of public health significance include aflatoxins 
(AFs), ochratoxin A (OTA), fumonisins, zearalenone (ZEA) 
and deoxynivalenol (DON) due to their frequent occurrence 
in agricultural products and their adverse health effects in 
humans (Schatzmayer and Streit, 2013). Exposure tends to 
be highest in low income communities where food may be 
grown and stored locally, where there is a low diversity in 
diet and where socioeconomic deprivation contributes to 
malnutrition (Wild and Gong, 2010). A number of adverse 
health effects have been reported in various mycotoxins, 
with varying degrees of evidence. In regions where 
mycotoxin contamination of food is often high, there are 
often also high levels of reproductive health problems in 
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Abstract
It is well established that mycotoxin exposure can have adverse effects on reproductive health resulting to poor 
reproductive potential. The most studied mycotoxin in relation to poor reproductive health in humans is aflatoxin, 
although fumonisins, trichothecenes and zearalenone have also been reported to impair reproductive function and 
cause abnormal foetal development. These potent fungal toxins contaminate many food products making them a 
prominent agricultural, food safety and public health challenge, especially in Africa due to little or lack of mycotoxin 
regulation in agricultural products. Neonates can be exposed to aflatoxins in utero, as the toxins pass from mother to 
the foetus through the placenta. This exposure may continue during breast feeding, to the introduction of weaning 
foods, and then foods taken by adults. The consequences of aflatoxin exposure in mothers, foetus and children 
are many, including anaemia in pregnancy, low birth weight, interference with nutrient absorption, suppression of 
immune function, child growth retardation and abnormal liver function. In males, reports have indicated a possible 
relationship between aflatoxin exposure and poor sperm quality culminating in infertility. Maternal exposure to 
fumonisin during early pregnancy has been associated with increased risk of neural tube defects among newborns in 
regions where maize is the common dietary staple with the possibility of chronic fumonisin exposure. Furthermore, 
zearalenone has been linked to precocious puberty and premature thelarche in girls, correlating with extremely 
high serum oestrogen levels. This review presents an overview of the several reports linking aflatoxins, fumonisins, 
trichothecenes, and zearalenone exposure to poor reproductive health outcomes in Africa, with emphasis on birth 
outcomes, foetal health and infertility.
Keywords: endocrine disrupters, mycotoxins, neural tube defects, maternal and foetal health, infertility
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humans, such as high rates of infertility, low birth weight, 
pre-term delivery, stillbirths and birth abnormalities 
(Agarwal et al., 2015; Mascarenhas et al., 2012; McClure 
et al., 2009; Ota et al., 2014). Causes of these reproductive 
health problems are multifactorial and undernutrition 
and poverty are major contributors. Nevertheless, the 
occurrence of chronic mycotoxin exposure in populations 
affected by high rates of such reproductive health problems 
has led to research into the possible role of mycotoxins 
as causes of these conditions. Most human research on 
the adverse reproductive health effects of mycotoxins has 
focused on AFs, fumonisins and ZEA, but there are also 
several animal and in vitro studies reporting reproductive 
toxicity and endocrine disrupting effects of other 
mycotoxins, including DON, OTA, nivalenol (NIV), and 
T-2 toxin. However, this review is focused on the evidence 
that AFs, fumonisins, DON, NIV and ZEA contribute to a 
range of human reproductive health conditions, with aim 
of guiding future research and interventions designed to 
reduce harmful exposures to mycotoxins and reduce the 
risk of these adverse reproductive health outcomes.
2. Aflatoxins
AFs are major metabolites of Aspergillus flavus and 
Aspergillus parasiticus and are frequent contaminants of 
peanuts, maize, rice, and oil seeds, particularly in Africa and 
South Asia (IARC, 2002). The naturally occurring classes of 
AFs are aflatoxin B1 (AFB1), aflatoxin B2 (AFB2), aflatoxin 
G1 (AFG1) and aflatoxin G2 (AFG2), and the hydroxylation 
forms commonly found in milk and urine (aflatoxins M1 
and M2 (AFM1 and AFM2)) (Kensler et al., 2011). AFB1 is 
the most toxic and is a major risk factor for hepatocellular 
carcinoma, particularly in individuals with chronic hepatitis 
B virus infection. Acute toxicity causes liver failure and 
can be fatal. AFB1 has also been associated with growth 
impairment in children and modification of immune 
function (Wild et al., 2015). In addition, recent evidence 
indicates AFs may be involved in adverse reproductive 
health outcomes (Shuaib et al., 2010a; Smith et al., 2017a).
Prevalence of aflatoxin exposure among pregnant women 
in Africa
Due to the ubiquitous nature of AFs and their common 
contamination of food products, biomarkers of aflatoxin 
exposure have been detected in the blood of pregnant 
women and infant cord blood in different African countries. 
For example, Wild et al. (1991) assessed umbilical cord 
blood from neonates of 30 Gambian women, and found that 
97% of maternal sera and 70% of cord sera were positive 
for the aflatoxin-albumin (AF-alb) adducts. AF-alb adducts 
were also detected in 119 out of 119 (100%) maternal blood 
(range: 4.8-260.8 pg/mg albumin) and cord blood of 48 out 
of 99 (48.5%) newborns (range: 5.0-89.6 pg/mg albumin) in 
The Gambia (Turner et al., 2007). In a subsequent study in 
Ghana, AF-alb adducts (range: 0.44-268.73 pg/mg albumin) 
were detected in 100% of 755 pregnant women (Shuaib et 
al., 2010b). Another cross-sectional study showed that AF-
alb adducts were found in 34 of 98 (35%) serum samples 
(range: 3.0-35.1 pg/mg albumin) and AFM1 (range: 4.1-408.6 
pg/mg creatinine) in 44 of 93 (48%) urine samples taken 
from pregnant Egyptian women (Piekkola et al., 2012), 
whilst AF-alb adducts were detected in 100% (99/99) of 
pregnant Gambian women (range: 4.8-521.6 pg/mg albumin 
during early pregnancy; 4.4-556.5 pg/mg albumin during 
later pregnancy) (Castelino et al., 2014). In a more recent 
study, urinary AFM1 was reported in 30% of 1,580 pregnant 
women in Zimbabwe (Smith et al., 2017b). Furthermore, De 
Vries et al., (1989) detected AFs in 37% of 101 cord bloods in 
Kenya. AFs in cord blood have also been detected in 54.7% 
of deliveries in United Arab Emirates, 37.8% in Nigeria, 48% 
in Thailand, 57% in Taiwan and 34% in Ghana (reviewed 
in Shuaib et al., 2010a). The high prevalence of AFs and 
AF-alb adducts in cord blood is an indication that AFB1 
crosses the placental barrier reaching the foetal circulation 
(Denning et al., 1990; Wild et al., 1991).
Determinants of aflatoxin exposure during pregnancy in 
Africa
Several authors have reported the major determinants of AF 
exposure in pregnancy among African women. In a study 
in Ghana, pregnant women with higher economic status 
and low parity were 30-40% less likely to have high AF-
alb adducts in their blood (Shuaib et al., 2012). Economic 
status is a major driving factor of AF exposure in Africa as 
those with low economic status are more likely to consume 
foods that are prone to AF contamination (e.g. maize and 
groundnuts) and possibly, take unremoved mouldy foods 
(Jolly et al., 2006; Leroy et al., 2015; Shuaib et al., 2012). 
However, geographical location, seasonality and dietary 
practices were significant determinants of AF exposure 
among pregnant women in Zimbabwe as determined by 
urinary AFM1 (Smith et al., 2017b). In a study in Gambia, 
we found that seasonal differences affected AF-alb adduct 
levels in Gambian pregnant women with high levels 
occurring during the dry season and women in their late 
pregnancy also had higher AF-alb adducts compared to 
those in early pregnancy (Castelino et al., 2014). Subsequent 
study suggest participants’ ethnicity, village of residence and 
the number of individuals in the household as significant 
predictors of high AF-alb adduct levels in Ghanaian general 
population (Jolly et al., 2006). The number of individuals 
in a household in most cases determines the quality of 
food consumed in Africa and high household numbers 
could predispose to the consumption of low quality foods 
which may be contaminated with mycotoxins (Jolly et 
al., 2006). In contrast, there was a significant correlation 
between blood AF-lysine adduct in adult Kenyan women 
and poverty level (Leroy et al., 2015). Notwithstanding the 
country and exposure biomarker applied, it is generally 
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accepted that geographical location, season and calendar 
year, socio-economic status, pre-and post-harvest practices, 
and household dietary practices are major determinants of 
AFs exposure in pregnancy (Smith et al., 2017b).
Maternal aflatoxin exposure and adverse pregnancy 
outcomes
AF exposure in pregnant women is mostly due to ingestion 
of contaminated diets, and has been suggested to contribute 
to poor maternal, neonatal and child health, especially in 
Africa and Asia (Shuaib et al., 2010a). The consequences of 
AF exposure in mothers, neonates and children are many 
and they include anaemia in pregnancy, intrauterine growth 
restriction and low birth weight, interference with nutrient 
absorption, suppression of immune function, child growth 
retardation and abnormal liver function (Wild et al., 2015).
Aflatoxin exposure during pregnancy, intrauterine growth 
restriction and low birth weight
Maternal AF exposure during pregnancy has been associated 
with intrauterine growth restriction and low birth weight, 
anaemia in pregnancy, neonatal jaundice, and growth 
faltering in early childhood in Africa (Table 1). Studies 
evaluating aflatoxin exposure through the presence of AFs 
or metabolites in serum (AFB1, AFB2, AFG1 and AFG2) or 
milk (AFM1 and AFM2), instead of validated AF exposure 
biomarkers (urinary AFM1 and AFB1-N7-guanine adduct 
or serum AF-alb adduct), reported associations between 
exposure and low birth weight (De Vries et al., 1989), 
stillbirth (Lamplugh et al., 1988) and neonatal jaundice 
(Ahmed et al., 1995; Abulu et al., 1997). In The Gambia, 
AF-alb adduct levels during pregnancy were associated with 
lower height-for-age (-0.207 z scores, P=0.044) and lower 
weight-for-age (-0.249 z scores, P=0.012) in infants during 
the first year of life (Turner et al., 2007). Shuaib et al. (2010c) 
also reported that of 755 pregnant Ghanaian women, those 
in the highest quartile of AF-alb (AF-alb: >11.34 pg/mg 
albumin) were more likely to have babies with low birth 
weight (odds ratio (OR) 2.09; 95% confidence interval (CI) 
1.19-3.68) compared to the lowest quartile (AF-alb: ≤2.67 
pg/mg albumin). Mycotoxin exposure biomarkers have 
advantages over exposure assessments through food and/or 
foodstuff as they provide more objective data on mycotoxins 
exposure, and correct for heterogeneous distribution of the 
mycotoxins in food. Validated biomarkers of AF exposure 
are biomarkers shown in epidemiological studies to be 
quantitatively associated with dietary AF intake and include 
urinary AFM1 and AFB1-N7-guanine adduct as well as 
serum AF-alb adduct (Kensler et al., 2011). Urinary AFM1 
and AFB1-N7-guanine adduct reflect AF exposure in the 
previous 24-48 h while serum AF-alb adduct identifies AF 
exposure over the previous 2-3 months, and are therefore 
applied to detect short-term and long-term exposure, 
respectively. Several reports have shown a significant 
correlation between serum AF-alb adduct and urinary 
AFM1 levels (Chen et al., 2018; Jolly et al., 2006; Piekkola et 
al., 2012) and therefore, reports involving these biomarkers 
should be accepted with confidence.
One postulated mechanism by which AF exposure could 
impact on growth is through interference with the insulin-
like growth factor (IGF) axis. In Kenyan children exposed 
to AFs in utero, reduced IGF1 mRNA and protein levels 
were observed (Castelino et al., 2015). In vitro exposure 
of human hepatocyte cell line 16 (HHL-16) to AFB1 also 
significantly decreased IGF1 mRNA and protein expression 
(Castelino et al., 2015). Furthermore, differential DNA 
methylation of fibroblast growth factor-12 (FGF12) and 
insulin growth factor 1 receptor (IGF1R) genes were 
observed in the white blood cells from Gambian infants 
whose mothers were exposed to AFs during early pregnancy 
(Hernandez-Vargas et al., 2015). IGF1 and IGF1R genes are 
mediators of the growth hormone and plays major roles 
in embryonic development, foetal and post-natal growth 
(Baker et al., 1993). It has been reported that serum IGF1 
levels are significantly reduced in infants with intrauterine 
growth restriction compared to controls (Leger et al., 1996). 
Although these studies provide an insight into the negative 
effects of AFs on the IGF1 axis leading to perinatal and 
neonatal growth restriction and low birth weight, these 
mechanisms remain unclear and needs to be further 
explored to demonstrate causal association. As AFB1 is 
known to cross the placental barrier, it is also possible that 
foetal cytochrome (CYP) 3A7 bioactivates AFB1 to the 
toxic AFB1-8, 9-epoxide after placental transfer of AFB1 
from maternal blood during pregnancy resulting in foetal 
toxicity (Partanen et al., 2010).
Aflatoxin exposure in pregnancy and maternal anaemia
Anaemia in pregnancy is one of the leading causes of 
maternal mortality during child birth in Africa and Asia 
(Khan et al., 2006; IFPRI, 2016). Recent studies assessing 
AF-alb adduct levels in pregnant women in Ghana reported 
significant association between AF exposure and anaemia in 
pregnancy as well as low birth weight. Shuaib et al. (2010b) 
reported that AF-alb level was associated with anaemia in 
pregnancy with the odds of being anaemic increasing by 
21% (OR, 1.21, P=0.01) and each quartile of AF-alb reaching 
an 85% increased odds in the highest quartile (AF-alb: 
>11.34 pg/mg albumin) compared to the low quartile (AF-
alb: ≤2.67 pg/mg albumin) group (OR, 1.85; CI, 1.16-2.95).
Experimental studies have shown that AF promotes the 
haemolysis of erythrocytes, inhibits haematopoiesis, impairs 
iron absorption, affects haemoglobin levels and induces 
microcytic hypochromic anaemia in multiple animal species 
(Andretta et al., 2012; Eisa and Metwally, 2011; Kumar and 
Balachandran, 2005; Lanza et al., 1978; Verma and Raval, 
1991; Yousef et al., 2003). It has also been hypothesised that 
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Table 1. Human studies on mycotoxins exposure, reproductive and developmental toxicity.1
References
Study design and location
Mycotoxin levels detected Outcome Comments
De Vries et al., 1989
A cross-sectional study of 
125 mother-infant pairs in 
Kenya.
AFs were detected in 53% of maternal blood 
samples and in 37% of cord samples. 
Maternal blood: AFB1 (89-11,574 pg/ml); 
AFM1/AFM2 (12-1,689 pg/ml). Cord blood: 
AFB1 (86-6,819 pg/ml); AFM1/AFM2 (17-656 
pg/ml).
No correlation between AF 
levels in maternal and cord 
blood. Female infants born to 
mothers exposed high levels 
AF had significantly lower 
birth weight compared to 
those from mothers with non-
detectable blood AF.
AF occurrence in maternal and 
cord blood was significantly 
higher in the rainy season 
than in the dry season. 
Stillbirths occurred in mother 
and cord bloods with high AFs 
levels.
Turner et al., 2007
Maternal and cord blood 
was collected from 138 
singleton infants followed 
for 14 months in The 
Gambia.
AF-alb adducts detected by ELISA and 119 
(100%) maternal blood, 48 (48.5%) cord 
blood and 13 blood samples (11%) from week 
16 children had detectable AF-alb adducts. 
Maternal: 23.3-64.1 pg/mg albumin (mean: 
38.9 pg/mg albumin); Cord: 2.5-7.9 pg/mg 
albumin (mean: 2.5 mg/mg albumin).
Higher AF-alb levels in maternal 
blood (at 5 and 8 months of 
pregnancy) were associated 
with lower HAZ (-0.207 SD; 
P=0.044) and WAZ (-0.247 
SD; P=0.012) scores in 
children during the first year 
of life. Maternal AF-alb in 
pregnancy was not associated 
with infant weight or length 
at birth.
There was seasonal variation 
in maternal AF-alb levels. 
Maternal AF-alb levels 
was significantly higher in 
blood samples collected in 
December – March compared 
to samples collected in either 
April – November (P<0.001).
Shuaib et al., 2010b
Blood from 755 pregnant 
Ghanaian women.
Blood AF-lysine adduct detected by HPLC 
and all the blood samples had detectable 
AF-lysine adduct (range: 0.44-268.73 pg/mg 
albumin; Mean: 10.9±19.00 pg/mg albumin).
Pregnant women with AF-lysine 
in the highest quartile (>11.34 
pg/mg) were 2.09 times more 
likely to have low birthweight 
infants (95% CI: 1.19-3.68).
Other parameters showed a 
trend towards an increased 
risk (Ptrend=0.007).
Shuaib et al., 2010c
Blood from 755 pregnant 
Ghanaian women.
Blood AF-lysine adduct detected by HPLC 
and all the blood samples had detectable 
AF-lysine adduct (range: 0.44-268.73 pg/mg 
albumin; Mean: 10.9±19.00 pg/mg albumin). 
30.3% had anaemia.
Very high blood AF-lysine 
adduct was significantly 
associated with the odds of 
being anaemic (OR: 1.85; CI: 
1.16-2.95).
The odds of being anaemic was 
stronger in pregnant women 
after exclusion of those with 
malaria, intestinal parasitic 
infection or low folate level. 
AF exposure in pregnancy 
was associated with anaemia.
Lamplugh et al., 1988
Blood samples from 188 
cord bloods and 264 
breast milk samples from 
Ghana and 77 mother-
infants pairs from Nigeria 
with maternal and cord 
blood.
AFs detected in 64 (34%) cord bloods and 
90 (34%) breast milk from Ghana, and 16 
maternal (21%) and 9 (12%) cord blood from 
Nigeria. Ghana cord: AFB1 (185-43 ng/l); 
AFB2 (11-925 ng/l); AFM1 (34-7,320 ng/l); 
AFM2 (30-572 ng/l); AFG1 354-1,354 ng/l), 
AFG2 (37 ng/l); AFL (117 ng/l). Ghana breast 
milk: AFB1 (130-8,218 ng/l); AFB2 (49-50 
ng/l); AFL (64-270 ng/l); AFM1 (20-1,816 ng/l); 
AFM2 (16-2,075 ng/l). Nigeria maternal blood: 
AFB1 (540-10,390 ng/l); AFB2 (28-33 ng/l); 
AFM1 (38-483 ng/l); AFM2 (48-3,480 ng/l). 
Nigeria cord blood: AFB2 (0-10 ng/l); AFM1 
(25-8,942 ng/l); AFM2 (208-378 ng/l)
AF occurrence and 
concentration was detected 
more in the rainy season 
than in dry season. Presence 
of AF biomeasures in cord 
blood confirmed AF crosses 
placental barrier to the foetus.
One stillbirth was recorded 
from a mother from high AFs 
exposure level (AFB1: 553 
ng/l).
Maxwell et al., 1994
A cross-sectional study to 
evaluate the effect of AFs 
and napthols exposure on 
birth weight of 625 babies 
at delivery in Ibadan, 
Nigeria.
AFs were found in 91 (14.6%) of the cord 
bloods. The distributions and levels were: 
AFB1 (168-69,973 ng/ml); AFB2 (15-144 ng/
ml); AFM1 (32-11,354 ng/ml); AFM2 (14-3,644 
ng/ml).
In utero AF and napthols 
exposure did not correlate 
with birth weight at delivery.
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References
Study design and location
Mycotoxin levels detected Outcome Comments
Ibeh et al., 1994
Case-control study to 
determine the association 
of AFs exposure and male 
infertility using 50 infertile 
males and 50 fertile 
controls from Benin City, 
Nigeria.
The mean AF concentrations was 1.660±0.04 
µg/ml in infertile men and 1.041±0.01 µg/
ml in the fertile control group). Aflatoxins 
were detected in 40% of the infertile men 
compared to 8% in Fertile controls.
AF exposure was associated 
with increased sperm 
abnormality.
Higher percentage of sperm 
abnormality (50.0%) was 
found in infertile males 
with high exposure to AFs 
compared to the fertile control 
group (10.0-15.0%).
Uriah et al., 2001
A case-control study to 
examine the association 
between aflatoxin 
exposure and human 
reproduction in Benin City, 
Nigeria using 30 infertile 
males and 25 fertile 
controls.
Serum and semen AFB1 concentrations 
ranged from 700-1,392 ng/ml and 60-148 
ng/ml, respectively in infertile males with 
values significantly higher than those in the 
fertile group. One semen sample with no live 
spermatozoa (azoospermia) had an AFB1 
levels as high as 1,450 ng/ml. Approximately 
37% of semen and blood of infertile men had 
detectable aflatoxins than the controls.
AF exposure suggested as a 
contributory factor to male 
infertility in Nigeria.
AFs exposure caused 
decreased sperm 
concentration and increased 
sperm abnormalities.
Mohammed et al., 2014
A case-control hospital-
based study that 
examined the AFs 
concentration in semen 
samples from 108 (60 
infertile men and 48 fertile 
controls) visiting Sohag 
University Hospital, Egypt.
AFB1 was present in 25% of the semen of 
infertile patients, compared to 2.1% among 
the controls (P=0.0007).
AFB1 exposure was suggested 
as a potential contributor to 
idiopathic infertility in males.
Severe reduction in sperm 
count, reduced motility, high 
percentage of sperm with 
abnormal morphology, and 
high viscosity in the semen 
of the infertile group(P<0.05) 
compared to the fertile group.
Szuets et al., 1997
Study on young girls 
with early thelarche/
mastopathy in Southern 
Hungary.
ZEA was detected in the serum of 5 out of 36 
early patients with concentrations ranging 
from 18.9-103 µg/ml.
ZEA reported to be associated 
with early thelarche/
mastopathy.
Childhood ZEA exposure was 
associated with early breast 
development in young girls.
Massart et al., 2008
Study on serum samples 
of 32 girls with CPP and 
31 female healthy female 
controls from North-West 
Tuscany, Italy.
ZEA (723.5-1,143.9 pg/ml) and α-ZOL (104.5-
108.5 pg/ml) were detected from the serum of 
6 of the 32 girls with CPP. All the controls had 
no detectable mycotoxins.
ZEA suspected of inducing 
central maturation of the 
hypothalamic-pituitary-
gonadal axis causing CPP in 
exposed girls.
Mycotoxin positive patients had 
higher height, weight and 
height velocity compared to 
those who had no mycotoxin 
detected in their serum.
Bandera et al., 2011
A cross-sectional study to 
determine the association 
between the exposure of 
ZEA and its metabolites 
on body size and breast 
development in 163 girls 
from New Jersey, USA.
78.5% of the girls had detectable levels of ZEA 
and its metabolites (ZEA: 0.05-33.12 ng/ml; 
α-ZOL: 0.003-10.69 ng/ml).
ZEA suspected to have anti-
oestrogenic effect.
Girls exposed to ZEA and its 
metabolites presented with 
shortness and had late-onset 
of breast development.
Tomaszewski et al., 1998
Endometrial tissue 
specimens collected from 
49 women (endometrial 
adenocarcinoma n=27, 
endometrial hyperplasia 
n=11, normal proliferative 
endometrium n=11).
The concentration of ZEA in 3 endometrial 
hyperplasia samples was 47.8±6.5 ng/ml 
and 167.0±17.7 ng/ml in 22 adenocarcinoma 
samples.
ZEA suspected to be 
associated with hyperplastic 
and neoplastic endometrium.
Normal endometrial samples 
had no detectable 
concentration of ZEA. Also 8 
hyperplastic and 5 neoplastic 
endometrial samples had no 
detectable concentration of 
ZEA.
1 AF = aflatoxin; AF-alb = aflatoxin-albumin; AFL = aflatoxicol; AFs = AFB1, AFB2, AFM1, AFM2, AFG1 and AFG2; CI = confidence interval; CPP = central 
precocious puberty; ELISA = enzyme-linked immunosorbent assay; HAZ = height-for-age Z-score; HPLC = high performance liquid chromatography; OR 
= odd ratio; SD = standard deviation; WAZ = weight-for-height Z-score; ZEA = zearalenone; α-ZOL = α-zearalenol.
Table 1. Continued.
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aflatoxin could cause anaemia by impairing iron absorption 
and bioavailability as well as inhibition of erythropoiesis 
(Smith et al., 2017a). To date, no human research has been 
performed to test this hypothesis.
Aflatoxin exposure and male infertility
Male infertility is increasing in both developed and 
developing countries (Mascarenhas et al., 2012). The 
prevalence of male infertility varies between developed 
countries with USA standing at 6% (Chandra et al., 2013) 
whereas it is higher in UK at 10-15% (Oakley et al., 2008). 
In sub-Saharan Africa, infertility prevalence rates are 
higher and range from 20-35% (Etuk, 2009). The ‘infertility 
belt’ stretching from West Africa, through Central to 
East Africa are known geographical regions with high 
infertility prevalence in Africa (Etuk, 2009). Our previous 
case control study has pointed to environmental and food-
borne contaminants (e.g. pesticides, phthalates, bisphenol 
A, mycotoxins, cadmium, lead, arsenic, and caffeine) as 
possible causes of male infertility in Africa (Okonofua et al., 
2005), but the exact contaminants have yet to be identified. 
Subsequently, we have argued for further research to 
uncover the role of food contaminants, such as AFs in the 
rising incidence and prevalence of male infertility in the 
African region (Eze and Okonofua, 2015) as these toxins 
are major contaminants of local foods consumed in the 
region. Although preliminary experiments have identified 
possible roles for AFs in the causation of infertility in the 
animal models (Agnes and Akbarsha, 2003; Ahmed et al., 
2012; Ortatatli et al., 2002; Supriya et al., 2014), this is yet to 
be confirmed in humans, where little research is available.
There are a few human studies reporting the potential of 
AF exposure in causing male infertility in Africa (Table 
1). In Nigeria, Ibeh et al. (1994) examined the presence 
of AFs in the semen of 100 adult males consisting of 50 
infertile men and 50 fertile men to ascertain if there is a 
relationship between AFs and male infertility. Among the 
50 semen samples from the infertile group, 20 (40%) had 
detectable level of AFs and 50% of the semen samples had 
sperm with abnormalities in sperm count, morphology 
and motility whereas only 4 (8%) of the fertile males had 
AFs in their semen with 10-15% of the semen showing 
sperm abnormalities. In addition, the concentrations of 
AFs found in the semen of infertile males were higher 
than fertile males. When adult male albino rats were fed 
with animal feed contaminated with 8.5 µg AFB1/g feed 
for 14 days, they had decreased sperm count, abnormal 
morphology, reduced motility and viability (Ibeh et al., 
1994). In an in vitro study, AFs also significantly reduced 
the motility of sperm cells (Ibeh et al., 2000). In a case-
control study involving 30 infertile and 25 fertile males, 
Uriah et al. (2001) found significantly higher levels of 
AFB1 in the blood (700-1,392 ng/ml) and semen (60-48 
ng/ml) of the infertile men compared to the fertile men. 
A case-control hospital-based study that examined the 
AF concentrations in semen samples from 108 men (60 
infertile men and 48 fertile controls) visiting a University 
Hospital in Egypt has also been reported (Mohammed et 
al., 2014). It was observed that AFB1 was present in 25% 
of the semen of infertile patients, compared to 2.1% found 
in fertile controls (P=0.0007). Among the infertile patients 
with AFB1 exposure, severe reduction in sperm count, 
reduced sperm motility, high percentage of sperm with 
abnormal morphology, and high viscosity in the semen were 
evident compared to the fertile group with low detectable 
AFB1 (Mohammed et al., 2014).
The negative effects of AFB1 on sperm parameters could 
be attributed to its ability to interfere with the biosynthesis 
of androgens and alteration of testicular function resulting 
to the inhibition of spermatogenesis and sperm maturation 
giving rise to the production of abnormal sperm cells 
(Adedara et al., 2014; Agnes and Akbarsha, 2003; Ahmed 
et al., 2012; Picha et al., 1986; Supriya et al., 2014). For 
instance, in adult male roosters fed with diets containing 
AFB1 (5, 10 and 20 mg/l) for 8 weeks, a suppression of 
spermatogenesis, abnormalities in sperm morphology and 
count, reduced plasma testosterone and testicular atrophy 
were observed compared to the control adult roosters 
(Ortatatli et al., 2002). In a more recent study, exposure of 
bull semen to AFB1 (0.1, 1, 10 and 100 μM) in vitro for 4 h 
decreased sperm viability, caused hyper-polarisation of the 
sperm mitochondrial membrane and negatively affected 
sperm DNA integrity (Komsky-Elbaz et al., 2018).
3. Fumonisins
Fumonisins are primarily produced by Fusarium 
verticillioides (previously known as Fusarium moniliforme) 
and Fusarium proliferatum which contaminate maize 
and maize-based food products, although their presence 
in other agricultural products (e.g. sorghum, cowpea, 
asparagus, rice and farro) has been occasionally reported 
(Bulder et al., 2012; Rheeder et al., 2016; Voss et al., 2006). 
Human exposure to fumonisin B1 (FB1), B2 (FB2) and B3 
(FB3) is high in regions where home-grown maize are used 
as dietary staples (Gong et al., 2008; Van der Westhuizen 
et al., 2011). FB1 is the most common of the numerous 
fumonisin analogues and the most studied fumonisins, 
and has been classified as a possible human carcinogen 
(Group 2B) by the International Agency for Research on 
Cancer (IARC, 2002).
Consumption of FB1-contaminated maize and maize-
based foods has been associated with high occurrence of 
oesophageal cancer in the former Transkei region of South 
Africa (Misihairabgwi et al., in press; Rheeder et al., 1992) 
and Linxian region of China (Sun et al., 2007). Similarly, 
in Mazandaran Province of Iran where there is also a high 
incidence of oesophageal cancer, increased concentrations 
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of fumonisins have been detected in maize grown in the area 
(Alizadeh et al., 2012; Shephard et al., 2002; Yazdanapanah 
et al., 2006). In animals, FB1 has been linked to spontaneous 
equine leukoencephalomalacia (Marasas et al., 1988; Smith 
et al., 2002), porcine pulmonary oedema (Harrison et al., 
1990; Hascheck et al., 2001), liver and kidney toxicity in 
different animal species (Bolger et al., 2001; Voss et al., 
2001), and liver and kidney cancer in rodents (Gelderblom 
et al., 1991; Howard et al., 2001a,b).
Fumonisin exposure, reproductive toxicity and birth 
defects
Growth retardation, delayed or incomplete ossifications, 
cleft palate or hydrocephalus, and foetal death have also 
been found in pregnant animals fed with FB1-contaminated 
feeds (Voss and Riley, 2013). Studies evaluating the 
reproductive and developmental toxicity of FB1 in humans 
are very rare. However, consumption of FB1 contaminated 
feeds have been reported to impair the reproductive 
potential of Syrian hamsters (Floss et al., 1994), rabbits 
(Ewuola and Egbunike, 2010), rats (Flynn et al., 1996; Gbore 
et al., 2012) and chicken embryos (Bacon et al., 1995; Javed 
et al., 1993; Zacharias et al., 1996). Gbore and colleagues 
have performed several studies to examine how dietary 
FB1 exposure in piglets and boars affect their reproductive 
function and they observed that such exposure caused 
delay in puberty in piglets and impaired sperm production 
and semen quality of boars (Gbore and Egbunike, 2008; 
Gbore, 2009a,b).
In humans, fumonisins are reported to be environmental 
risk factor for birth defects, notably neural tube 
defects (NTDs). NTDs (spina bifida, exencephaly and 
craniorhachischisis or meningio-myeloceole) are foetal 
malformations occurring as a result of failure of the 
embryonic neural tubes to close properly during the early 
period of gestation (Voss and Riley, 2013; Voss et al., 
2006). Maternal exposure to high concentrations of FB1 
through the ingestion of contaminated maize and maize-
based foods during early pregnancy has been associated 
with increased risk of NTDs among newborns in regions 
known to consume maize as staple foods (Hendricks, 1999; 
Marasas et al., 2004; Melnick and Marazita, 1998; Missmer 
et al., 2006). In the Transkei region of South Africa and 
Cameron County, Texas (USA) along the Texas-Mexico 
border, where maize is a dietary staple and where there is 
high chronic fumonisin exposure, there have been reports 
of high incidence of NTDs (Hendricks, 1999; Marasas et al., 
2004; Missmer et al., 2006). The incidence of NTDs in these 
regions is known to be 6-10 times higher compared to the 
average NTDs incidence rate found globally (≈10/10,000 
live births) (Gelineau-Van Waes et al., 2009; Hendricks, 
1999; Marasas et al., 2004).
A high incidence of NTDs (27 per 10,000 live births) was 
observed in the newborns of Mexican-American women 
living along the Texas-Mexico border who conceived 
between 1990 and 1991 (Hendricks, 1999). As a result, 
Missmer et al. (2006) conducted a population-based case-
control study among Mexican-American women who 
delivered newborns affected by NTDs between 1995 and 
2000 to evaluate if maternal fumonisin exposure during 
pregnancy was associated with NTDs in neonates. In this 
study, Missmer and colleagues assessed serum sphinganine 
to sphingosine (Sa:So) ratio of 163 Mexican-American 
women with NTD-affected pregnancies and 189 Mexican-
American women who delivered babies without NTDs 
within the study period. In addition, fumonisin levels were 
determined from 146 household corn tortillas and 114 
tortillas obtained from grocery stores to estimate pre-
conceptional dietary fumonisin exposure. The maternal 
serum Sa:So ratio ranged from 0.08 to 0.36 whereas 
fumonisin levels in tortillas ranged from non-detectable 
to 1,690 ng/g. Moderate consumption of tortilla compared 
to low consumption during the first trimester of pregnancy 
was associated with increased OR with NTDs in newborns 
after adjusting for body mass index, serum B12 and folate, 
and date of conception (OR: 2.4; 95% CI: 1.1-5.3). However, 
higher intakes of tortillas resulted to either a slight decrease 
in NTDs incidence or absence of NTDs. With regard to 
the maternal serum Sa:So ratio, higher levels of fumonisin 
exposure was associated with higher incidence of NTDs 
in newborns whereas those with the highest Sa:So ratio 
(>0.35) had low incidence of NTDs in newborns. It was 
suggested that at the highest estimated dietary or maternal 
serum fumonisin exposure, miscarriages or stillbirth might 
have occurred resulting to low incidence of NTD in this 
group (Missmer et al., 2006). Worthy of note is that this 
study estimated fumonisin exposure by measuring FB1 in 
foodstuff which has previously failed to provide accurate 
data on human exposure due to heterogeneous distribution 
of mycotoxins in food (Shephard et al., 2007). In addition, 
Missmer et al. (2006) applied maternal serum Sa:So ratio 
as a biomarker of fumonisin exposure. Although serum 
and urinary Sa:So ratio is suggested as a useful biomarker 
of fumonisin exposure in animals (Van der Westhuizen et 
al., 2001), it failed to correlate with human dietary exposure 
to fumonisins (Van der Westhuizen et al., 2008, 2010). 
The method of fumonisin exposure assessment applied 
by Missmer et al. (2006) could have inaccurately estimated 
fumonisin exposure and results should be interpreted with 
caution. Therefore, future studies should apply urinary FB1 
biomarker which has been shown to correlate well with 
human dietary fumonisin exposure (Gong et al., 2015; 
Shirima et al., 2013;Van der Westhuizen et al., 2011).
In animal studies, FB1 has been shown to induce NTDs in 
cultured mouse embryos (Sadler et al., 2002), and altered 
embryogenesis and caused NTDs development in foetus 
of pregnant mouse exposed during the early gestation 
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(Gelineau-Van Waes et al., 2005). Although FB1 is suggested 
as an etiologic agent in the development of NTDs, other 
factors including genetics and maternal nutrition play an 
important role in pregnancy outcome and dietary folic acid 
supplementation prior and during pregnancy is known 
to reduce the occurrence of NTDs (Greene and Copp, 
2005). The potential for FB1 to cause NTDs is primarily 
attributed to its structural similarity with sphingamine and 
sphingosine (Gelineau-Van Waes et al., 2005). FB1 and other 
fumonisins competitively interfere with ceramide synthase 
which is involved in the de novo synthesis of complex glyco-
sphingolipids resulting to the accumulation of sphingamine 
and sphingosine in tissues, serum and urine (Bolger et al., 
2001; Merrill et al., 2001; Riley and Voss, 2006; Voss and 
Riley, 2005; Voss et al., 2006). It has been postulated that 
NTDs are induced by fumonisins as a result of decreased 
concentration of complex sphingolipids, disruption of 
lipid rafts and impairment in the function of the high 
affinity placental carriers (folate binding protein 1 in mice 
and folate receptor alpha in humans) involved in folate 
transport causing folate deficiency in the foetus during 
early pregnancy and failure of the foetal neural tube to close 
properly (Gelineau-Van Waes et al., 2005, 2009, 2012; Voss 
and Riley, 2013; Voss et al., 2001). In addition, the complex 
glycol-sphingolipids are important in the maintenance 
of cell membrane integrity, cell growth and migration, 
cell differentiation, cell morphology and endothelial cell 
permeability and therefore, disruption of sphingolipid 
metabolism by fumonisins can negatively affect embryonic 
morphogenesis and cell apoptosis (Merrill et al., 2001; Yahia 
and Kamata, 2017). Based on these studies discussed above, 
the negative impacts of FB1 on reproductive function in 
animal and in vitro models cannot be ignored as there is a 
homology in organ systems between animals and humans.
4. Trichothecenes
The trichothecenes are toxic sesquiterpenoid mycotoxins 
produced by Fusarium, Stachybotrys and Myrothecium 
species of fungi during their growth in food and/or the 
environment (Pestka, 2010a,b). The broad family of 
trichothecenes have been classified into four groups: types 
A, B, and D based on the substitution pattern of the tricyclic 
12, 13 epoxytrichothec-9-ene core structure (Escrivá et 
al., 2015). Type A trichothecenes include T-2 toxin, HT-2 
toxin, neosolaniol and diacetoxyscirpenol, whereas the type 
B group are fusarenon-X, NIV and DON and its 3-acetyl 
and 15-acetyl derivatives. The detailed toxicological effects 
and molecular mechanisms of trichothecenes toxicity has 
been reviewed in Pestka (2010a,b) and Escrivá et al. (2015).
Reproductive and developmental health effects of 
deoxynivalenol exposure
DON is one of the type B trichothecenes and is known 
to cause disruption of gastrointestinal permeability, 
impair growth hormone signalling, dysregulate the 
expression of genes involved in inflammatory response, 
immunotoxicity, haematological disorders, and alteration 
of the neuroendocrine responses in humans and animals 
(Pestka, 2010a,b). The molecular mechanisms underlying 
these pathological effects involve the causation of oxidative 
damage, induction of apoptosis and autophagy, alteration 
of membrane integrity, and inhibition of DNA, RNA and 
protein synthesis (Payros et al., 2016; Pestka, 2010b). The 
effects of DON on human reproduction and development 
are scarce, however, there is literature reporting its adverse 
effects on reproduction and development in animal and in 
vitro models (Yu et al., 2017a).
DON has been implicated in the disruption of oocyte 
maturation, embryo resorption and foetal malformation 
in mice (Hou et al., 2014; Khera et al., 1982, 1984; Yu et 
al., 2017b), rats (Collins et al., 2006), and swine (Alm et al., 
2002, 2006). In a study to assess the toxic effects of DON on 
mouse embryo, Khera et al. (1982) exposed pregnant mice 
in their gestation days (GD: 8-11) to DON (0.5-25 mg/kg/
body weight (bw)) through oral gavage. DON at 0.5 mg/
kg/bw had no maternal and foetal toxicity, however, at 1, 
2.5 and 5 mg/kg/bw DON caused foetal malformation. In 
addition, there was embryo resorptions in mice treated with 
5, 10 and 25 mg/kg/bw whereas significant reduction in live 
foetuses were observed at >5 mg/kg/bw. In a subsequent 
study, maternal toxicity, foetal malformation and embryo 
resorption were reported in mice and rats exposed to DON 
at >1 mg/kg/bw (Debouck et al., 2001; Khera et al., 1984). 
Similarly pregnant rabbits fed with DON contaminated 
diet showed 100% incidence of embryo resorption in the 
1.8-and 2.0 mg/kg groups and decreased mean foetal 
weight in the 1.0 and 1.6 mg/kg group (Khera et al., 1986). 
However, none of the doses caused foetal malformation 
or showed teratogenic potential. In accordance with the 
above results, Hou and colleagues found that exposure 
of mice with DON-contaminated maize (3.875 mg/kg/
diet) for 4 weeks resulted in poor oocyte indices and low 
developmental competence of the ovaries (Hou et al., 2014). 
Taken together, these studies indicate that a high exposure 
to DON during pregnancy could directly induce foetal 
malformation or indirectly affect embryonic and foetal 
development as a result of maternal toxicity (Collins et 
al., 2006). With regard to studies on rats treated orally 
with DON, the CONTAM Panel (EFSA, 2017a) sets the 
no-observed-adverse-effect-level as 1.0 mg/kg bw per day 
for reproductive endpoints, 1.0 mg/kg bw per day for foetal 
toxicity and 0.5 mg/kg bw per day for maternal toxicity.
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The toxicity of DON to male germ cell in animals have 
also been reported. For instance, exposure of mice to 
DON induced testicular germ cell degeneration, decreased 
absolute caudal epididymal sperm numbers, caused 
reduction in caudal epididymal weights, and reduced 
serum testosterone levels (Sprando et al., 1999, 2005). 
This is supported by an in vitro study in which exposure 
of MA-10 murine Leydig cell line to DON increased the 
release of reactive oxygen species, significantly reduced cell 
viability and caused significant decline in forskolin-induced 
progesterone secretion after 24 h of exposure (Savard et al., 
2016). In a more recent study, we showed that DON was 
strongly cytotoxic to MA-10 cells after 48 h of exposure 
with concentrations as low as 29.63 ng/ml (0.1 µM) and 
296.32 ng/ml (1 µM) showing significant cytotoxicity (Eze et 
al., 2018). Urinary concentrations of 436 ng/ml (1.471 µM) 
and 1,238 ng/ml (4.178 µM) have been reported for DON 
and its conjugates in pregnant women (Sarkanj et al., 2013; 
Wells et al., 2016) and therefore, the concentrations causing 
cytotoxic effects on MA-10 cells have clinical relevance.
DON can be transferred through the placenta to the foetus 
in pregnant sows (Goyarts et al., 2007; Dänicke et al., 
2007) and it is likely that human foetus will be exposed to 
DON during pregnancy. In an in vitro placental perfusion 
using BeWo cell line, Nielsen et al. (2011) showed that 
DON was transported across the membrane and caused a 
dose-dependent decrease in the secretion of beta-human 
chorionic gonadotrophin (β-hCG). Normal β-hCG level 
is required for the proper functioning of the placenta 
and foetal development, therefore the reduction in this 
important hormone further supports the embryo resorption, 
foetal death and malformation reported in animal studies. 
In addition, it has been argued that DON exposure in 
females causes the accumulation of reactive oxygen species, 
induction of autophagy and apoptosis, and alteration of 
epigenetic modification in the female reproductive system 
resulting to DON-induced reproductive and developmental 
toxicity (Han et al., 2016; Yu et al., 2017b).
In summary, it is plausible that human exposure to DON 
either in utero or during post-natal period can impair 
reproduction and development. Therefore, a properly 
designed in vitro and in vivo bioassays as well as human 
epidemiological study is required to provide stronger 
evidence establishing the association between exposure to 
DON and adverse reproductive health outcomes in humans.
Reproductive and developmental toxicity of nivalenol
Similar to DON, the effects of NIV on reproduction and 
development have also been reported (Pestka, 2010a), 
although there is no literature on the reproductive health 
effects in human beings. Ito and colleagues reported that 
intraperitoneal administration of NIV (0.1-1.5 mg/kg bw/
day) to pregnant ICR mice from 7-15 days of gestation 
caused vaginal bleeding in 60% of the exposed mice, 
stillbirths and induced 48-88% embryo deaths, especially at 
0.5 and 1.5 mg/kg bw (Ito et al., 1986). It was also observed 
that the injection of 3 mg NIV/kg bw on gestation day 7 was 
highly toxic to both the embryo and placenta culminating 
in stillbirths within 48 h. In a similar study, maternal and 
embryo toxicity which resulted to intrauterine growth 
retardation was reported when pregnant mice (GD: 7-15) 
were either fed with 6-30 mg/kg/diet of NIV or 1-20 mg/
kg bw of NIV by oral gavage, particularly at the highest 
doses (Ito et al., 1988). Teratogenic effects were not 
observed in any of the concentrations of NIV used either 
in contaminated feed or oral gavage (Ito et al., 1988). When 
female F344/DuCrj rats were fed diets containing NIV 
at 6.25, 25 and 100 mg/kg for 90 days, histopathological 
features showed increase in atretic ovarian follicles and 
interstitial glands, impaired corpora lutea development, and 
uterine atrophy with dioestrus endometrial mucosa change 
in those fed the highest dose (100 mg/kg) (Takahashi et al., 
2008; Sugita-Konishi et al., 2008). However, there was no 
adverse effect on the primary and secondary follicles. On the 
other hand, there was no effect on the reproductive system 
in male F344/DuCrj rats fed with same diet containing the 
same amount of NIV (Takahashi et al., 2008; Sugita-Konishi 
et al., 2008). In contradiction to the above studies, pregnant 
sows fed with maize contaminated with NIV did not affect 
any reproductive parameters assessed (Williams and Blaney, 
1994). It can be deduced that female rodents are more 
susceptible to NIV than their male counterparts and pigs.
5. Zearalenone
Zearalenone (ZEA) produced by Fusarium species is also 
considered as one of the common mycotoxins posing a 
threat to human and animal reproductive health (Zinedine 
et al., 2007). ZEA is primarily converted by hydroxysteroid 
hydrogenases to phase I metabolites, including α-zearalenol 
(α-ZOL), β-zearalenol (β-ZOL), α-zearalanol (α-ZAL), 
β-zearalanol (β-ZAL) and zearalanone (ZAN) (EFSA, 
2017b). ZEA and the metabolites are known endocrine 
disruptors due to their resemblance to 17β-oestradiol, 
enabling them to disrupt the binding of 17β-oestradiol to 
oestrogen receptors. Both in vivo and in vitro studies show 
that α-ZOL has higher oestrogenic potency compared to 
ZEA, whereas β-ZOL has lower oestrogenic potency (EFSA, 
2017b). It has been reported to cause hyper-oestrogenism 
with attendant reproductive disorders in farm animals 
(Zinedine et al., 2007). In animals, ZEA is known to 
reduce testosterone levels and induce abnormal sperm 
quality in males (Yang et al., 2007; Zatecka et al., 2014), 
and cause ovarian follicle atresia, uterine hyperplasia, and 
degeneration of oocyte meiotic chromatin in females (Alm 
et al., 2006; Obremski et al., 2003; Skorska-Wyszyńska et 
al., 2005; Yamini et al., 1997). Despite the evidence that 
ZEA causes adverse effects on reproduction in animals, 
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there are currently no published reports of associations of 
ZEA with infertility or birth defects in human populations.
There have been some reports of the association of ZEA 
exposure with central precocious puberty (CPP), premature 
thelarche, and hyperplastic and neoplastic endometrium 
(Table 1). In a study comprising 32 girls with CPP and 31 
healthy female controls, elevated levels of ZEA and α-ZOL 
were detected in the serum of six of the 32 cases (Massart 
et al., 2008, 2010). In response to a high incidence of CPP 
in the Viareggio region of North-West Tuscany in Italy, 
Massart et al. (2008) recruited 32 girls (17 from Viareggio 
region and 15 from Pisa) with idiopathic CPP visiting the 
Paediatric Endocrine Centre of Pisa and matched them 
with 31 healthy female controls. In these groups, ZEA and 
its metabolites were assessed and matched with height, 
weight and height velocity, body mass index, bone age, 
and gonadal secretion. Among the 17 CPP patients from 
Viareggio region, 6 (35%) had detectable levels of ZEA 
(mean: 933.7±200.3 pg/ml) and α-ZOL (mean: 106±1.9 
pg/ml) whereas none of the 15 CPP patients from Pisa 
had ZEA or its metabolites detected in their serum. It 
was also observed that the six girls with ZEA and α-ZOL 
exposure had higher height, weight and height velocity after 
12-month triptorelin (gonadotrophin-releasing hormone 
agonist) treatment compared to the 26 CPP patients and 
31 healthy controls with non-detectable serum ZEA 
and α-ZOL (Massart et al., 2008). As a result of these 
parameters, ZEA and α-ZOL exposure were suggested as 
predisposing factors of idiopathic CPP in prepubertal girls. 
However, the ZEA and its metabolites could not be detected 
in the other 26 girls with CPP giving an inconclusive result 
and therefore, other environmental contaminants may have 
been predisposing factors of the reported CPP (Massart 
et al., 2008, 2010). Previously, ZEA exposure was also 
speculated to be associated with early breast development 
among young Hungarian girls (Szuets et al., 1997). In this 
report, five of 36 early telarche/mastopathy patients in the 
South-East Region of Hungary had high serum level of ZEA 
(18.9-103.5 µg/ml) and it was speculated that ZEA could be 
a contributory factor for the development of early telarche/
mastopathy (Szuets et al., 1997). However, this study could 
not clearly state statistically how the concentration of ZEA 
was related to early telarche/mastopathy development 
and so, should be interpreted with caution. Other studies 
also suggest that ZEA may be a contributory factor to 
premature thelarche and idiopathic CPP in prepubertal 
girls (Schoental, 1983; Deng et al., 2012; Asci et al., 2014). In 
contradiction to these studies above, Bandera and colleagues 
conducted a cross-sectional study comprising 163 girls 
(age: 9-10 years) from New Jersey in USA to evaluate the 
effects of exposure to ZEA and its metabolites on body 
size and breast development (Bandera et al., 2011). In this 
study, 78.5% of the girls had urinary ZEA (0.05-33.12 ng/
ml), α-ZOL (0.003-10.69 ng/ml), β-ZOL (0.05-1.10 ng/
ml), α-ZAL (0.02-0.57 ng/ml), β-ZAL (0.04-0.60 ng/ml) 
and ZAN (0.07-3.31 ng/ml), with those who consumed 
beef and popcorn the day prior to urine collection having 
significantly higher concentrations compared to those who 
did not take these foods. Girls who had detectable levels 
of urinary ZEA and its metabolites had lower height and 
delayed onset of breast development after adjusting for 
age, body mass index, isoflavone intake, and recruitment 
year, and it was concluded that exposure to ZEA and 
its metabolites had anti-oestrogenic effects on the girls 
(Bandera et al., 2011). The difference in the results reported 
in this study compared to the previous studies could be 
attributed to the small sample size of ZEA exposure (5 or 
6), detection of ZEA and metabolites in serum instead of 
urine, and having subjects comprising of girls undergoing 
CPP treatment (Bandera et al., 2011). Therefore, a well-
designed longitudinal studies with larger sample size, the 
inclusion of people with different ethnic background and 
countries, and the use of valid ZEA exposure biomarkers 
would certainly provide stronger evidence for establishing a 
causal association. In addition, reproductive hormones such 
as oestrogen, progesterone, follicle stimulating hormone, 
and luteinising hormone should be evaluated and included 
in the statistical analysis as they can also influence the onset 
of puberty in girls.
However, biologically relevant doses of ZEA (5-10 mg/kg 
bw) caused precocious puberty in immature female rats as 
a result of early induction of the hypothalamic kisspeptin 
(KISS1)-G-protein coupled receptor-54 (GPR54) signalling 
pathway which is responsible for the initiation of puberty 
onset, regulation of the hypothalamo-pituitary-gonad 
axis and reproductive function (Kriszt et al., 2015; Yang 
et al., 2016). The precocious puberty in treated rats were 
evidenced through the induction of Kiss1, GPR54 and GnRH 
(Gonadotropin-releasing hormone) expressions in the 
hypothalamus at both mRNA and protein levels (Yang et al., 
2016). This could be the same mechanism through which 
ZEA causes precocious puberty in human beings since 
mutations and/or inactivation of the GPR54 and/or KISS1 
genes in humans and mice (gpr54 and kiss1) has been linked 
to reproductive dysfunction, including delayed puberty 
onset, abnormal oestrus cycles and infertility (Kirilov et 
al., 2013; Semple et al., 2005).
6.  Mycotoxin co-exposure and implication for 
human reproductive health
Multiple mycotoxin exposure biomarkers have been 
reported in several population studies which show that 
human beings are often simultaneously exposed to mixtures 
of mycotoxins (Table 2). For instance, in the former Transkei 
region of South Africa, Shephard and colleagues examined 
53 urine samples and demonstrated that mixtures of 
biomarkers such as DON, ZEA, FB1 and OTA as well as 
their metabolites can be detected frequently in the human 
urine samples (Shephard et al., 2013). Similarly, out of 
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Table 2. Summary of selected studies on human exposure to mycotoxin mixtures.
References Country No. Individuals 
examined
No of 
positive 
samples (%)
Mycotoxin exposure 
biomarkers detected1
Co-exposure in a single individual1
Ahn et al., 2010 Korea2 12 11 adults, 
1 child
12 (100%) AFM1, OTA AFM1, OTA
Rubert et al., 2011 Spain2 27 adults not stated AFG2, OTA, DON not stated
Solfrizzo et al., 2011 Italy2 10 adults 10 (100%) OTA, DON DON, OTA
Warth et al., 2012a Austria2 27 adults 26 (96%) DON, DON-3-GlcA, DON-
15-GlcA
DON, DON-3-GlcA, DON-15-GlcA
Warth et al., 2012b Cameroon2 175 145 HIV-positive 
adults, 
30 HIV-negative 
adults
110 (63%) AFM1, OTA, FB1, FB2, 
DON, DON-3-GlcA, 
DON-15-GlcA, NIV, ZEA, 
ZEA-14-GlcA, α-ZOL
AFM1, OTA, FB1, FB2, DON, DON-3-
GlcA, DON-15-GlcA, NIV
Ediage et al., 2012 Belgium2 40 adults 9 (23%) DON, OTA, OTα, 4-OH-
OTA, ZEA, CIT, β-ZOL
DON, OTA, OTα, ZEA, β-ZOL
Shephard et al., 
2013
South Africa2 53 adult women 53 (100%) OTA, FB1, DON, DON-
3-GlcA, DON-15-GlcA, 
NIV, ZEA, ZEA-14-GlcA, 
α-ZOL, β-ZOL
OTA, FB1, DON, DON-3-GlcA, DON-
15-GlcA, ZEA, ZEA-14-GlcA, α-ZOL, 
β-ZOL
Rodriguez-Carrasco 
et al., 2014
Valencia2 54 38 adults, 
16 children
37 (68.5%) HT-2, NIV, DON DON-HT2, DON-NIV
Ezekiel et al., 2014 Nigeria2 120 81 adults, 
20 adolescents, 
19 children
61 (50.8%) AFM1, DON, DON-15-GlcA, 
FB1, FB2, OTA, ZEA, 
ZEA-14-GlcA
distribution of mycotoxins: 75% (46/61) 
had a single mycotoxin and 25% 
(15/61) had more than 1 mycotoxin [8 
had 2 different mycotoxins, 5 had 3 
different mycotoxins, 2 had 4 different 
mycotoxins, 7 had more than one 
mycotoxin/metabolite]
Cao et al., 2013 China3 10 6 men, 
1 pregnant woman, 
3 lactating women
not stated AFB1, AFB2, HT-2, DON, 
DOM-1, ZEA, α-ZOL, 
β-ZOL, FB1, FB2, AFM1, 
OTA, NEO, T-2 Triol
3 samples had AFBs and FBs.
Abia et al., 2013 Cameroon2 145 HIV-positive 
adults (29 male, 
116 female), 
30 HIV-negative 
adults
110 (63%) DON, NIV, ZEA, OTA, FB1, 
FB2, DON-15-GlcA, DON-
3-GlcA, ZEA-14-GlcA, 
α-ZOL, AFM1
DON, OTA, NIV, FB1, ZEA, AFM1, FB2
Ediage et al., 2013 Cameroon2 220 children 160 (73%) OTA, DON, AFM1, FB1, 
ZEA, α-ZOL, β-ZOL
co-occurrence of 2, 3 and 4 mycotoxins 
was 35, 5 and 5%, respectively
Solfrizzo et al., 2014 Italy2 52 26 males, 
26 females
52 (100%) DON, OTA, AFM1, FB1, 
ZEA, α-ZOL, β-ZOL
distribution of mycotoxin mixtures in 
samples: 2 (DON, ZEA, FB1, OTA, 
AFM1); 27 (DON, ZEA, FB1, OTA); 
20 (DON, ZEA, OTA); 1 (DON, ZEA, 
OTA, AFM1); 2 (ZEA and OTA)
Gerding et al., 2014 Germany2 101 adult volunteers 87% DON, ZEA, CIT, T-2, ENNB, 
DON-3-GlcA, ZEA-14-
GlcA, DH-CIT
DON-ENNB-ZEA, DON-CIT-T-2, DON-
CIT, DON-ZEA-DON-ENNB
Gerding et al., 2015 Bangladesh2, 
Germany2, 
Haiti2
287 95 adult 
Bangladeshis, 
50 adult Germans, 
142 adult Haitians
Bangladesh 
(87%), 
Germany 
(80%), 
Haiti (68%)
DON, OTA, CIT, ENNB, 
AFM1, FB1, α-ZOL, DON-
3-GlcA, DH-CIT
DON-CIT-OTA-FB1, DON-CIT-OTA, 
DON-OTA-ENNB, CIT-OTA-ENNB, 
CIT-OTA-FB1, AFM1-CIT-OTA, 
AFM1-CIT-DON, ENNB-OTA, DON-
OTA, CIT-OTA, CIT-FB1, CIT-ENNB, 
AFM1-CIT
1 4-OH-OTA = 4-hydoxyl-ochratoxin A; AFB1 = aflatoxin B1; AFG2 = aflatoxin G2; AFM1 = aflatoxin M1; CIT = citrinin; DH-CIT = dihydrocitrinone; DOM-1 = 
de-epoxy-deoxynivalenol; DON = deoxynivalenol; DON-15-GlcA = deoxynivalenol-15-glucuronide; DON-3-GlcA = deoxynivalenol-3-glucuronide; ENNB 
= enniatin B; FB1 = fumonisin B1; FB2 = fumonisin B2; HIV = human immunodeficiency virus; NEO = neosolaniol; NIV = nivalenol; OTA = ochratoxin 
A; OTα = ochratoxin alpha; ZEA = zearalenone; ZEA-14-GlcA = zeralenone-14-O-glucuronide; α- and β-ZOL = α- and β-zearalenol; α-ZOL-14-GlcA 
= α-zearalenol-14-O-glucuronide; α-ZOL-7-GlcA = α-zearalenol-7-O-glucuronide; β-ZOL-14-GlcA = β-zearalenol-14-O-glucuronide; β-ZOL-16-GlcA = 
β-zearalenol-16-O-glucuronide.
2 Only urine samples were analysed.
3 Urine, faeces, breast milk and amniotic fluid were analysed.
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220 urine samples obtained from children in Cameroon, 
160 (73%) had biomarkers for OTA, DON, AFM1, FB1, 
ZEA, α-ZOL and β-ZOL. Co-occurrence of 2, 3 and 4 
mycotoxins was 35, 5 and 5%, respectively (Ediage et al., 
2013). In a recent study in Nigeria, mycotoxins and their 
metabolites, including AFM1, DON, OTA, FB1, FB2, FB3, 
ZEA, zearalenone-14-O-glucuronide and deoxyvalenol-15-
O-glucuronide were detected in 51% of urine samples from 
120 volunteers involving children, adolescents and adults, 
and 25% of them indicated multi-mycotoxin exposure 
(Ezekiel et al., 2014). In another study in Italy (Solfrizzo 
et al., 2014), biomarkers of ZEA + ZOLs (100%), OTA 
(100%), DON (96%), FB1 (56%), and AFM1 were found in 
urine samples with 52% exposures involving mixtures of 
DON, ZEA, FB1 and OTA. Furthermore, in a three-year 
survey of the global occurrence of mycotoxins using 7,049 
feed and feedstuff samples, it was reported that 48% were 
contaminated by two or more mycotoxins (Rodrigues and 
Naehrer, 2012). Globally, the rate of co-occurrence of AFB1, 
DON, ZEA, OTA and fumonisins in feeds and feedstuff 
continues to be high (Schatzmayer and Streit, 2013) and 
therefore, requires toxicological consideration. Despite 
the fact that human beings can be exposed to a range of 
mixtures of mycotoxins, most toxicological studies have 
only taken into account of the effects of exposure to a single 
mycotoxin. However, combinations of mycotoxins can be 
agonistic, additive or antagonistic, and therefore, could 
pose a significant threat to human reproductive health 
(Alassane-Kpembi et al., 2013).
Epidemiological research evaluating the effects of 
mycotoxin mixtures on human reproduction is currently 
scarce, however, there are few in vitro studies evaluating 
their effects on the female and male reproductive system. 
Pizzo and colleagues examined the negative effects of 
single and combinations of DON, α-ZOL and β-ZOL on 
cell proliferation, steroidogenesis and gene expression of 
bovine small-follicle granulosa cells after 48 h exposure in 
vitro (Pizzo et al., 2016). The presence of α-ZOL (3.1 μM) 
and β-ZOL at 31 μM significantly inhibited the growth 
of the bovine small-follicle granulosa cells whereas DON 
(0.1-3.3 μM) had no significant effects on the graulosa 
cell proliferation. Worthy of note is that the exposure 
of the granulosa cells to binary combinations of α-ZOL 
(3.1 μM) and DON (3.3 μM) significantly increased cell 
proliferation, indicating synergistic effects. In addition, 
combination of α-ZOL with DON or β-ZOL inhibited 
oestradiol secretion higher than the effects obtained in 
single treatment of each of the toxins, but had no significant 
effect on progesterone production. In the same study 
(Pizzo et al., 2016), co-exposure of DON and β-ZOL to 
the granulosa cells decreased cell proliferation, and strongly 
inhibited oestradiol production. Similarly, DON with 
α-ZOL or β-ZOL caused a significant up-regulation in the 
expression of CYP11A1 in IGF1 stimulated granuolsa cells. 
In a different study by Pizzo et al. (2015), the individual and 
combined effects of DON and α-ZOL on cell proliferation 
and steroidogenesis of follicle-stimulating hormone (FSH) 
plus IGF1 stimulated bovine large follicle granulosa cells 
was examined after 48 h of exposure. It was observed that 
DON (3.3 μM) significantly reduced cell proliferation by 
22% whereas α-ZOL (0.09 and 0.31 μM) stimulated large 
granulosa cell growth. Interestingly, binary combination 
of DON (0.01 μM) and α-ZOL (0.09 μM) stimulated cell 
proliferation by 45% when compared to vehicle control, 
although this was not significantly different from the 
stimulatory effect of single treatment with α-ZOL (0.09 
μM). It was also reported that that DON (0.33 and 3.3 μM) 
significantly impaired both oestradiol and progesterone 
production compared to controls. Interestingly, co-
exposure of DON and α-ZOL to the granulosa cells in the 
presence of FSH inhibited progesterone secretion, but 
induced oestradiol production in the granulosa cells (Pizzo 
et al., 2015). Taken together, it can be deduced that co-
exposure of DON with α-ZOL or β-ZOL at concentrations 
relevant to human exposure can impair bovine ovarian cell 
proliferation and steroidogenesis which may negatively 
affect normal follicle development and oocyte function. 
Therefore, human research should be taken to elucidate 
the molecular mechanisms through which co-exposure 
of DON with α-ZOL or β-ZOL affect ovarian function 
and morphology.
In a subsequent study, Albonico et al. (2016) evaluated the 
effects FB1 in single and combined with DON, α-ZOL or 
β-ZOL on bovine granulosa cells in the presence of IGF1 in 
vitro. FB1 (30 ng/ml – 5 µg/ml), α-ZOL (5 µg/ml) and β-ZOL 
(30 ng/ml) had no significant effect on the bovine granulosa 
cell growth. However, combination of FB1 (30 ng/ml) with 
same concentration of β-ZOL significantly stimulated 
the cell growth. At higher concentrations, FB1 (5 µg/ml) 
strongly reduced cell numbers, and co-exposure of FB1 (5 
µg/ml) with β-ZOL (5 µg/ml) also inhibited cell numbers. 
It was also reported that co-treatment of FB1 with α-ZOL 
caused a significant decline in granulosa cell numbers, 
indicating either additive or synergistic effects as none of 
the mycotoxins had significant effect on cell numbers in 
a single exposure. On hormone production, FB1 (30 and 
100 ng/ml) had no effect on granulosa oestradiol secretion, 
but significantly stimulated its production at 5 µg/ml. In 
contrast, α-ZOL (5 µg/ml) and β-ZOL (5 µg/ml) strongly 
caused a decline in oestradiol production. In addition, 
combination of FB1 (5 µg/ml) with α-ZOL (5 µg/ml) had 
no effect, but a co-exposure with β-ZOL (5 µg/ml) caused a 
reduction in oestradiol secretion. Surprisingly, co-treatment 
of FB1 alone or in combination with DON, α-ZOL or β-ZOL 
did not affect bovine granulosa cell progesterone release. 
In contradiction with the work of Albonico et al. (2016), 
Cortinovis and colleagues reported that co-treatment of FB1 
with α-ZOL amplified the level of progesterone produced 
by porcine small granulosa cells in single toxin exposure 
(Cortinovis et al., 2014), indicating additive effects. The 
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difference in the response of porcine and bovine granuolsa 
cells to co-exposure of FB1 with α-ZOL could be as a result 
of the species sensitivity of these mycotoxins. For instance, it 
is well known that FB1 is more toxic to horses and pigs than 
to cattle (Albonico et al., 2016). In an in vitro study, Tatay 
et al. (2014) studied the cytotoxic and interactive effects 
of ZEA, α-ZOL and β-ZOL in ovarian (CHO-K1) cells. It 
was observed that binary or ternary combinations of these 
mycotoxins showed higher cytotoxicity than the individual 
toxins. In addition, co-exposure of ZEA with α-ZOL or 
β-ZOL generally showed additive effects either at 24, 48 or 
72 h of exposure. Interestingly, ternary mixtures of ZEA, 
α-ZOL and β-ZOL exhibited synergistic effects at lower 
concentrations (Tatay et al., 2014), further emphasising 
the need for the inclusion of mycotoxin mixtures in 
toxicological assessment. In summary, the co-occurrence 
of mycotoxins can cause perturbation in cell proliferation 
and dysregulation of endocrine function of ovarian cells, 
highlighting the significance of co-occurrence of mycotoxins 
to female reproductive health. Future research should 
also examine the role of co-occurrence of mycotoxins in 
placental morphology and function, embryogenesis and 
endometrial function.
The mechanisms through which mycotoxin mixtures can 
impact on testicular morphology and steroidogenesis also 
deserves attention. In a previous study, we have shown 
that DON, α-ZOL and OTA were strongly cytotoxic to 
MA-10 Leydig cells in vitro after 48 h of exposure (Eze et 
al., 2018). In the same study, OTA did not induce much 
cytotoxicity up to 16 μM when cells were treated with 
only this compound, but co-exposure of OTA with DON 
increased the cytotoxicity at 8-32 μM compared to DON 
or OTA alone. In addition, OTA had a synergistic effect 
on the cytotoxicity induced by ZEA, α-ZOL and β-ZOL. 
We also reported that combinations of DON/OTA, DON/
ZEA, DON/α-ZOL, DON/β-ZOL, OTA/ZEA, OTA/α-ZOL, 
and OTA/β-ZOL were generally additive and synergistic at 
low concentrations (Eze et al., 2018), raising the possibility 
that co-exposure to these mycotoxins could contribute to 
adverse male reproductive health in exposed populations.
7. Concluding remarks
Mycotoxins are contaminants of many staple food crops 
for human consumption, particularly in sub-Saharan Africa 
and South Asia making these toxins a major public health, 
food safety and economic problem. There is scientific 
evidence on the adverse reproductive health effects of 
human exposure to mycotoxins in Africa, including low 
birth weight, stillbirth, intrauterine growth restriction, 
maternal anaemia, NTDs and male infertility. However, this 
review identified papers that were mainly cross-sectional 
studies and most of the studies did not adjust for other 
factors that could affect low birth weight, intrauterine 
growth restriction, male infertility, stillbirth, and anaemia, 
such as malaria, hormonal pathology, malnutrition, poor 
food quality, and other infectious disease conditions.
At present, the molecular pathways through which 
mycotoxins induce reproductive and developmental toxicity 
are still not well understood. Future research should employ 
validated biomarkers of mycotoxin exposure in human 
epidemiological studies, and reproductive cell lines or 
primary cells representing the reproductive system of both 
genders to investigate possible molecular pathways in which 
mycotoxins affect the reproductive systems, the sex gametes, 
placental and endometrial function, and embryogenesis. In 
addition, randomised control trials evaluating the effects 
of mycotoxins and poor reproductive health outcomes in 
humans using validated exposure biomarkers are urgently 
needed. Lastly, intervention strategies should be put in 
place in Africa to mitigate mycotoxin contamination of food 
crops, especially those consumed by vulnerable groups such 
as pregnant women, infants and young children.
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